je.st
news
Tag: diabetes
MSD Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin
2013-07-26 16:16:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Sharpe and Dohme (MSD), known as Merck in the United States and Canada, issued the following statement regarding the conclusion of the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) review of GLP-1, or incretin-based, therapies, including sitagliptin. Language: English Contact: MSDMedia:Pam Eisele, +1-908-423-5042Michael Close, +1-267-305-1211Investor:Carol Ferguson, +1-908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: type
including
review
statement
Merck Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin
2013-07-26 15:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, issued the following statement regarding the conclusion of the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) review of GLP-1, or incretin-based, therapies, including sitagliptin. Language: English Contact: MerckMedia:Pam Eisele, 908-423-5042Mary Elizabeth Blake, 908-423-5550orInvestors:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: type
including
review
statement
UNM chosen to partner in diabetes study
2013-07-20 13:26:51| Biotech - Topix.net
The work will be supported by a $2.8 million grant from the National Institutes of Health over the next seven years.
Tags: study
partner
chosen
diabetes
A solid step toward vaccinating against type 1 diabetes
2013-06-27 21:17:21| CNET News.com
Scientists at Stanford are working on a vaccine to stop a type 1 diabetic's immune system from attacking the cells that make insulin. [Read more]
Tags: type
step
solid
diabetes
Diabetes drugs: Merck & Co wins injunction against Indian co
2013-06-25 17:21:37| Biotech - Topix.net
SD, a unit of US drugmaker Merck & Co, said it has won an injunction against India's Aprica Pharmaceuticals and a source said this will stop Aprica launching generic versions of two diabetes drugs in India.
Sites : [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] next »